Literature DB >> 2773897

Ultrastructural abnormalities in endoscopically and histologically normal and involved colon in ulcerative colitis.

G Delpre1, I Avidor, R Steinherz, U Kadish, M Ben-Bassat.   

Abstract

Twenty colonoscopies (eight complete or almost complete; 12 short) were carried out on 15 patients with ulcerative colitis with the aim of comparing the endoscopic aspects with the light and electron microscopic features in biopsies taken from multiple sites. Patients with severe attacks were examined without prior preparation (two examinations). When the attack was mild to moderate (11 examinations), or the patient was in remission (seven examinations), two saline enemas were given up to 1 h before examination. There was a favorable correlation between the endoscopic and light microscopic features in 94.7% of the biopsies (total number of biopsies, 76). The electron microscope findings greatly exceeded those observed by light microscope and indicated that the major abnormality resides within the colonic epithelial cells. Distinctive ultrastructural changes were present both in apparently uninvolved (endoscopically and histologically) parts of colon and in inactive stages of ulcerative colitis. These findings suggest that colonic mucosal involvement may be universal, persist during clinical remission, and precede the light microscopic findings. They also support the importance of maintenance therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2773897

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

1.  A new chronic ulcerative colitis model produced by combined methods in rats.

Authors:  Xue-Liang Jiang; Hui-Fei Cui
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.

Authors:  Aisha Nazli; Arthur Wang; Oren Steen; David Prescott; Jun Lu; Mary H Perdue; Johan D Söderholm; Philip M Sherman; Derek M McKay
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 3.  Stat3: friend or foe in colitis and colitis-associated cancer?

Authors:  Jie Han; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

4.  Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.

Authors:  S L-F Pender; V Chance; C V Whiting; M Buckley; M Edwards; R Pettipher; T T MacDonald
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

5.  Flavaglines Ameliorate Experimental Colitis and Protect Against Intestinal Epithelial Cell Apoptosis and Mitochondrial Dysfunction.

Authors:  Jie Han; Qian Zhao; Christine Basmadjian; Laurent Désaubry; Arianne L Theiss
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

6.  Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

Authors:  T King; W Biddle; P Bhatia; J Moore; P B Miner
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

7.  Depletion of neuroendocrine cells in rectal biopsy specimens from HIV positive patients.

Authors:  J B McCullough; P A Batman; A R Miller; P M Sedgwick; G E Griffin
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

8.  Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

Authors:  S Almer; L Franzén; G Olaison; K Smedh; M Ström
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

9.  Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.

Authors:  P Gibson; O Rosella; R Nov; G Young
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

10.  A new hypothesis for the aetiology of Crohn's disease--evidence from lipid metabolism and intestinal tuberculosis.

Authors:  W E Roediger
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.